Skip to main content
Nathalie Guibord, MD, Ophthalmology, Danville, PA

Nathalie M. Guibord MD

Cataract Related


Physician

Join to view full profile
  • 16 Woodbine LnDanville, PA 17821

  • Phone+1 570-271-6531

  • Fax+1 570-271-7146

Join Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 1 invite waiting!
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Nathalie Guibord, MD is a board certified ophthalmologist in Danville, Pennsylvania. She is currently licensed to practice medicine in Pennsylvania, New Mexico, and New Mexico.

Education & Training

  • UPMC Medical Education
    UPMC Medical EducationResidency, Ophthalmology, 1996 - 1999
  • McGill University Faculty of Medicine
    McGill University Faculty of MedicineClass of 1994

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1997 - 2026
  • PA State Medical License
    PA State Medical License 1999 - 2026
  • NM State Medical License
    NM State Medical License 1998 - 2004
  • NM State Medical License
    NM State Medical License 1998 - 2004
  • Ophthalmology
    American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2012-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2017

Publications & Presentations

PubMed

Press Mentions

  • Geisinger Honors 195 Providers for High Patient Satisfaction Ratings
    Geisinger Honors 195 Providers for High Patient Satisfaction RatingsJanuary 4th, 2022